Citation Impact
Citing Papers
Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease
2005
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.
1996
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease
1998
Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.
1984
Ten years' experience with an elemental diet in the management of Crohn's disease.
1990
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
1997
Corticosteroids for maintenance of remission in Crohn's disease
2003
Cytokines in inflammatory bowel disease
2014 Standout
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
2000
Anti-TNF strategies in stenosing and fistulizing Crohn?s disease
2004
Maintenance treatment of Crohn's disease
2003
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Management of Crohn's disease in adults
2001
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Ulcerative Colitis
2011 Standout
Drug Insight: aminosalicylates for the treatment of IBD
2007
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
2000
Exploration of the genetic aetiology of inflammatory bowel disease — implications for diagnosis and therapy
2004
Gut biogeography of the bacterial microbiota
2015 Standout
The genetics of Crohn disease: Complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives
1989
Guidelines for the management of inflammatory bowel disease in adults
2011
Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93
1997
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
2000
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Crohn's disease
2012 Standout
Oral Budesonide for Active Crohn's Disease
1994
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
2004
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
1991
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Surgery for Crohn Colitis Over a Twenty-Eight-Year Period: Fewer Stomas and the Replacement of Total Colectomy by Segmental Resection
2002
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Efficacy of parenteral methotrexate in refractory Crohn’s disease
2001
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Sulphasalazine and Prednisone Compared with Sulphasalazine for Treating Active Crohn Disease
1991
Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease
2002
Inflammatory Bowel Disease
2009 Standout
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
1995
Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial
1996
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Mechanisms in failure of infliximab for Crohn's disease
2000
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
2000
Cost of Illness of Crohn??s Disease
2002
Inflammation and Colon Cancer
2010 Standout
Inflammatory Bowel Disease
1991 Standout
Clinical Relevance of Serum Interleukin-6 in Crohn's Disease: Single Point Measurements, Therapy Monitoring, and Prediction of Clinical Relapse
1999
Ulcerative colitis
2012 Standout
10 Adjuvant post-operative therapy
1998
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial
1999
Mucosal flora in inflammatory bowel disease
2002
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
2004 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
A meta-analysis of the placebo rates of remission and response in clinical trials of active crohn’s disease
2004
A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease
1989
Intestinal mucosal barrier function in health and disease
2009 Standout
Does self-administration of a quality of life index for inflammatory bowel disease change the results?
1996
The influence of zinc status and malnutrition on immunological function in Crohn's disease
1991
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease
2004 Standout
Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial
2005
Ulcerative colitis
2016 Standout
Gut flora in health and disease
2003 Standout
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study
2007 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Inflammatory Bowel Disease
1996
Intestinal permeability and the prediction of relapse in Crohn's disease
1993
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
2000
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
2009
Oral pentasa in the treatment of active Crohn’s disease: A meta-analysis of double-blind, placebo-controlled trials
2004
Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease
1998
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Advances in the management of Crohn's disease: economic and clinical potential of infliximab
1998
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)
1998
Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease
2005
Time Trends in the Incidence and Disease Location of Crohnʼs Disease 1980-1995: A Prospective Analysis in an Urban Population in Germany
1999
Clinical, biological, and endoscopic picture of attacks of Crohn's disease
1990
Methotrexate for the Treatment of Crohn's Disease
1995
Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
1994
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Budesonide for Maintenance of Remission in Patients with Crohn's Disease in Medically Induced Remission: A Predetermined Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
2005
Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
1993
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
2011 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
The limitations of corticosteroid therapy in Crohn’s disease
2001
Guidelines for the management of inflammatory bowel disease in adults
2004
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.
1992
High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance
2005
Antibiotic therapy for treatment in relapse of intestinal Crohn's disease
1985
Prevalence and Mechanism of Nonsteroidal Anti-Inflammatory Drug–Induced Clinical Relapse in Patients With Inflammatory Bowel Disease
2006
Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).
1989
Sulfasalazine
1984
Maintenance Therapy in Crohn's Disease
2000
Low-Dose Cyclosporine for the Treatment of Crohn's Disease
1994
Budesonide versus prednisone in the treatment of active Crohn's disease
1998
Comparison of enteral nutrition and drug treatment in active Crohn's disease
1991
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
1996
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Inflammatory Bowel Disease
2010 Standout
Impaired natural killer cell activity in patients with inflammatory bowel disease: Evidence for a qualitative defect
1983
Budesonide for maintenance of remission in Crohn's disease
2014
T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
1990
Low Symptomatic Load in Crohn's Disease with Surgery and Medicine as Complementary Treatments
1998
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Budesonide for induction of remission in Crohn's disease
2015
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Traditional corticosteroids for induction of remission in Crohn's disease
2008
Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease
2008
Alterations of the Immune System in Ulcerative Colitis and Crohn's Disease
1988
Oral budesonide as maintenance therapy in Crohn’s disease—results of a 12‐month study
1998
Recent Developments in Nonspecific Inflammatory Bowel Disease
1982
Frequency of glucocorticoid resistance and dependency in Crohn's disease.
1994
Intravenous Corticotrophin vs. Hydrocortisone in the Treatment of Hospitalized Patients with Crohnʼs Disease: A Randomized Double-Blind Study and Follow-Up
1998
Preventing postoperative recurrence of Crohn's disease.
1997
Crohn's disease and the mycobacterioses: a review and comparison of two disease entities
1989
Works of H. Ehms being referenced
Immune status in Crohn's disease
1979
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
1984